secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2025-01-27T23:59:59+00:00
Accession:  0001411690-25-000008
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano Genomics effects 1-for-60 reverse stock split effective Jan 24, 2025
----------------------------------------------------------------------------

- Reverse stock split at ratio 1:60, effective 5:00 p.m. ET on January 24, 2025.
- Common stock begins trading split-adjusted on Nasdaq Capital Market under BNGO on Jan 27.
- No fractional shares issued; stockholders entitled to fractional shares receive cash in lieu.
- Proportionate adjustments to stock options, RSUs, warrants, and convertible debentures exercise prices and share counts.
- New CUSIP number for common stock post-split: 09075F404.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000141169025000008/0001411690-25-000008-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000141169025000008/bngo-20250124.htm
  HTML page:      https://secwatch.observer/filing/0001411690-25-000008

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer